Schizophrenia Research Today is a free monthly online journal that collates and summarizes the latest research about Schizophrenia, including details on paranoia, symptoms, treatment, depression, medication.

Reversal of oxidative stress by histamine H₃ receptor-ligands in experimental models of schizophrenia.

Mahmood D, Khanam R, Pillai KK, Akhtar M

Department of Pharmacology, Faculty of Pharmacy, Hamdard University, New Delhi, India.

Schizophrenia (SCZ) is a debilitating disorder afflicting around 1% of the world population. Recent literature reveals oxidative injuries contribute enormously to the pathophysiology of SCZ alongside other psychopathological disturbances. Histamine H3R-antagonists have shown dual mechanism of action in experimental models of SCZ. Firstly it prevents oxidative stress and secondly alleviates schizophrenic symptoms, particularly the negative symptoms and cognitive deficits. In the present study, histamine H3R-antagonists used were ciproxifan (3.0 mg/kg, ip) and clobenpropit (15 mg/kg, ip) markedly controlled the elevated levels of various oxidative stress markers, for example, thiobarbituric acid reactive substance (TBARS), glutathione (GSH), superoxide dismutase, catalase, etc., as a result of augmented oxidative stress in the experimental models of SCZ such as amphetamine (0.5 mg/kg, sc) and dizocilpine (MK-801) (0.2 mg/kg, ip) induced locomotor hyperactivity, apomorphine (1.5 mg/kg, sc) induced climbing behavior and haloperidol (2.0 mg/kg, po) induced catalepsy. The results of the present study revealed that H3R-antagonists possess antioxidant activity and could serve with dual mechanism by supplementing antioxidant needs of SCZ and at the same time controlling symptoms of SCZ.

Published 11 May 2012 in Arzneimittelforschung, 62(5): 222-9.
Full-text of this article is available online (may require subscription).

Articles on Schizophrenia published 11 May 2012:

Does maternal body mass index during pregnancy influence risk of schizophrenia in the adult offspring?   Obes Rev, 13(6): 518-27.

Maternal obesity in pregnancy has been linked with several adverse outcomes in offspring including schizophrenia. The rising prevalence of obesity may contribute to an increase in the number of schizophrenia cases in the near future; therefore, it warrants further exploration. We reviewed current evidence regarding maternal body mass index (BMI) in pregnancy and risk of schizophrenia in adult offspring. We searched PubMed and Embase databases and included studies that were based on large and ... [Abstract] [Full-text]

Articles on Schizophrenia published 8 May 2012:

Polypharmacy with antipsychotics, antidepressants, or benzodiazepines and mortality in schizophrenia.   Arch Gen Psychiatry, 69(5): 476-83.

[Abstract] [Full-text]

Elevated prefrontal cortex γ-aminobutyric acid and glutamate-glutamine levels in schizophrenia measured in vivo with proton magnetic resonance spectroscopy.   Arch Gen Psychiatry, 69(5): 449-59.

[Abstract] [Full-text]

Articles on Schizophrenia published 16 April 2012:

Allele-specific differences in activity of a novel cannabinoid receptor 1 (CNR1) gene intronic enhancer in hypothalamus, dorsal root ganglia, and hippocampus.   J Biol Chem, 287(16): 12828-34.

Polymorphisms within intron 2 of the CNR1 gene, which encodes cannabinoid receptor 1 (CB(1)), have been associated with addiction, obesity, and brain volume deficits. We used comparative genomics to identify a polymorphic (rs9444584-C/T) sequence (ECR1) in intron 2 of the CNR1 gene that had been conserved for 310 million years. The C-allele of ECR1 (ECR1(C)) acted as an enhancer in hypothalamic and dorsal root ganglia cells and responded to MAPK activation through the MEKK pathway but not in ... [Abstract] [Full-text]

Articles on Schizophrenia published 12 April 2012:

Transcript-specific associations of SLC12A5 (KCC2) in human prefrontal cortex with development, schizophrenia, and affective disorders.   J Neurosci, 32(15): 5216-22.

The neuron-specific K(+)-Cl(-) cotransporter SLC12A5, also known as KCC2, helps mediate the electrophysiological effects of GABA. The pattern of KCC2 expression during early brain development suggests that its upregulation drives the postsynaptic switch of GABA from excitation to inhibition. We previously found decreased expression of full-length KCC2 in the postmortem hippocampus of patients with schizophrenia, but not in the dorsolateral prefrontal cortex (DLPFC). Using PCR and rapid ... [Abstract] [Full-text]

Articles on Schizophrenia published 11 April 2012:

Cost-effectiveness of 12-month therapeutic assertive community treatment as part of integrated care versus standard care in patients with schizophrenia treated with quetiapine immediate release (ACCESS trial).   J Clin Psychiatry, 73(3): e402-8.

[Abstract] [Full-text]

ARVCF genetic influences on neurocognitive and neuroanatomical intermediate phenotypes in Chinese patients with schizophrenia.   J Clin Psychiatry, 73(3): 320-6.

[Abstract] [Full-text]

Analysis of gene variants previously associated with iloperidone response in patients with schizophrenia who are treated with risperidone.   J Clin Psychiatry, 73(3): 367-71.

[Abstract] [Full-text]

© 2004-2012 Schizophrenia Research Today. All Rights Reserved.